MOWRY ANNA (CFO and Treasurer) purchased 22.1% of their position (15K shares) of NAUTILUS BIOTECHNOLOGY, INC. on the open market
Open‑market purchase worth $11.5K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/2/2025ACC: 0001808805-25-000051
Officer· CFO and Treasurer
Since Jun 2021
+15K
Net shares
Net buyer
$11.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
15K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+15K
Price / share
$0.77
Trade value
$11.49K
% of position
22.1%
5/29/2025
68K→83K
Total
Net shares
+15K
Net value
$11.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/29/2025 | P · Purchase | +15K | $0.77 | $11.49K | 22.1% | 68K | 83K |
| Total | +15K | $11.49K | ||||||
Derivative Transactions0
No derivative transactions reported